Biotech start-up firm Detect Inc. has received a $22.8m award from the US Biomedical Advanced Research and Development Authority (BARDA) to develop a molecular diagnostic that can detect and distinguish between SARS-CoV-2 and influenza A/B in 30 minutes or less, BARDA announced recently.
The agency, which is part of the Department of Health and Human Services, said Detect will use the funds to...